Chemotaxis and cell migration play pivotal roles in normal physiological processes such as embryogenesis, inflammation, and wound healing, as well as in pathological processes including chronic inflammatory disease and cancer metastasis. Novel chemotaxis/migration inhibitors are desirable for developing effective therapeutics and probing molecular mechanisms. We describe a fluorescence-based phenotypic assay in a 1536-well plate format for highthroughput screening of novel inhibitors of chemotaxis/migration within complex libraries of thousands of compounds. Although the assay utilizes the unique cellular response properties of Dictyostelium, the compounds identified are able to inhibit chemotaxis of mammalian cells. In addition, a parallel cell cytotoxicity counter-screen with an ATP content assay is described that eliminates cytotoxic compounds from the screen. This novel compound screening approach enables rapid identification of novel lead compounds that inhibit chemotaxis in human and other cells for drug development and research tools. C 2017 by John Wiley & Sons, Inc. Keywords: cell migration r chemotaxis r LOPAC r acumen e X3 r Dictyostelium How to cite this article: Liao, X.-H. and Kimmel, A.R. 2017. A unique high-throughput assay to identify novel small molecule inhibitors of chemotaxis and migration.
INTRODUCTION
Cell chemotaxis and migration play pivotal roles in embryogenesis, immunity, and wound healing, as well as in cancer metastasis and chronic inflammation. Chemotaxis/migration inhibitors have potential as probes for mechanistic studies and as lead compounds for development of novel therapeutics. However, current cell-based chemotaxis assays are not easily adapted for high-throughput screening to systematically identify such novel inhibitors. identified from the Dictyostelium chemotaxis assay would reciprocally have the potential to similarly inhibit mammalian cell chemotaxis/migration; such inhibition is then easily verified in direct chemotaxis/migration assays.
Dictyostelium grow as single cells under nutrient-abundant conditions, but upon starvation, they enter a multicellular developmental program; as Dictyostelium sense nutrient depletion, centers of cAMP secretion become established and proximal Dictyostelium undergo chemotaxis within the cAMP gradients, relay the cAMP signal outwardly, and thus recruit additional cells to participate in chemotaxis and signal/relay. Cells ultimately form tight multi-cell structures at centers of cAMP signaling (Fig. 12.11 .1) and culminate development as a complex organism comprising highly differentiated cell types (Van Haastert and Veltman, 2007; Jin et al., 2008; McMains et al., 2008; Swaney et al., 2010; Williams, 2010) . A GFP reporter expressed under control of the cotB promoter, which is only activated in multi-cell aggregates (Nicol et al., 1999) , is used to assess chemotaxis-dependent aggregation (Fig. 12.11 .1). The GFP fluorescence signal is proportional to successful chemotaxis-dependent phenotypic aggregation and is quantified using the laser-scanning Acumen e X3 cytometer (Liao et al., 2016) .
This Dictyostelium aggregation assay has been automated and miniaturized in a 1536well plate format (Liao et al., 2016) using only 8000 cells/well (ß6 μl), with the GFP fluorescence rapidly assessed and with full data collection of an entire 1536-well plate Figure 12.11.2 Procedure for compound screening using the GFP reporter-based Dictyostelium chemotaxis-dependent aggregation assay. Each well of the 1536-well plate contains 8000 cells of Dictyostelium strain cotB/GFP, with various compounds (top). After 48 hr, the plates are imaged for GFP expression (middle), with selected individual wells with positive and negative signals enlarged (bottom).The left-most vertical row has the chemotaxis inhibitor latrunculin A at sequentially diluted concentrations from top to bottom. The second vertical row (from left) has 38 μM latrunculin A in all wells, as a full inhibitory control. The next two vertical rows have 0.38% DMSO as non-inhibitory controls. Different small molecule compounds are in the remaining rows. Note that non-inhibitory (DMSO control) wells show varied GFP expression levels, due to biological differences. In addition, the inhibitory effects of latrunculin A (or other compounds) on aggregation/GFP are not linear with dilution (see Fig. 12.11.3) . Inhibition should be viewed by alternative parameters, as either aggregation/GFP positive or negative. (See the Critical Parameters and Troubleshooting for full details.).
within 10 min (Fig. 12.11.2) . One to three aggregates are usually formed within each of the 1536 wells, while no aggregates are formed when chemotaxis is chemically inhibited (Fig. 12.11.2) . When the parameters of the Acumen e X3 are set to collect GFP signals only in objects >30 μm diameter, wells containing chemotaxis inhibitors have a zero GFP signal (at 100% inhibition; Figs. 12.11.2 and 12.11.3) . Thus, each well can be robustly classified in a binary fashion, with zero (no GFP expression) values indicative of strong chemotaxis inhibition and non-zero (GFP expression) values as non-inhibitory.
Since cytotoxic compounds that compromise cell viability may also inhibit chemotaxis (Fig. 12.11.4 ), a cell-based ATP-content assay was adapted to evaluate compound cytotoxicity to eliminate false positives (Miret et al., 2006) . Dictyostelium cells within aggregates are resistant to lysis, so the ATP-content assay uses a plating protocol that is non-permissive to aggregation.
To identify compounds with a wide range of activities and to avoid high false negatives of a traditional single-concentration assay, all compounds are serially diluted at a 1:5 titration ratio over 7 concentrations in a quantitative high-throughput screen (qHTS) for chemotaxis/migration inhibition. Thus, concentration-response curves can be immediately produced with the rich data obtained from a single qHTS experiment. The qHTS method further increases the reliability of our screening assays. This high-throughput, phenotypic assay can be used as a primary assay for screening chemotaxis/migration inhibitors from large chemical libraries. The identified candidate compounds are then further examined for inhibitory activity against mammalian migratory cells by low/middle-throughput chemotaxis assays, such as the monolayer scratch assay (Liang et al., 2007) , transwell assay (Ponath et al., 2000) , and EZ-TAXIScan assay (Liu et al., 2010) , among others (see below).
BASIC PROTOCOL 1

MINIATURIZED DICTYOSTELIUM AGGREGATION ASSAY FOR SCREENING OF CHEMOTAXIS/MIGRATION INHIBITORS
On solid substrata, Dictyostelium progress though all developmental stages, but the underbuffer assay used here promotes arrest at aggregation ( Fig. 12.11 .1). In Dictyostelium strain [cotB]:GFP, the GFP reporter is controlled by the cotB promoter, which is only activated after cells have undergone chemotaxis and aggregate formation (Nicol et al., 1999) . GFP expression in this strain is used to indicate success of chemotaxis and multicellular aggregation. The chemotaxis/aggregation assay has been miniaturized to a 1536-well plate format for large-scale screening. Latrunculin A is incorporated as an inhibitory control in all screening plates (Figs. 12.11.2 and 12.11.3) . Multiple parameters that might impact the assay have been optimized. 48 hr is chosen as an optimal incubation time to ensure that all aggregates attain peak GFP signals. 8000 cells/well is the optimal cell density for chemotaxis-dependent aggregation; at lower cell densities, aggregates do not form, and at higher densities, aggregates form without chemotaxis. The optimal incubation temperature is 20°to 23.5°C. The solvent DMSO has no impact on cell chemotaxis at experimental concentrations (i.e., 0.38% v/v), and is included as a noninhibitory control for all plates (Fig. 12.11 .2). Additional reagents and equipment for counting cells (UNIT 1.1; Phelan, 2015) 
Materials
Dictyostelium axenic culture [see dictyBase, Basu et al., 2013 for details]
1. Store Dictyostelium long-term in screw-cap vials at −80°C.
2. For daily use, maintain Dictyostelium as adherent cells in canted-neck culture flasks containing 10 ml of D3-T medium at ß21°C.
3. When cells are confluent, change medium every several days for the next 2 weeks. Healthy cells are required for the experiments; passage the cells by making a dilution between 1:100 and 1:20 (ß50×) into fresh medium and add to a new flask, or thaw a new storage vial when cells are cultured for more than 2 weeks.
4. Wash the cells from canted-neck culture flasks, count cell density, and inoculate the cells into a sterile >250 ml loosely capped Erlenmeyer flask containing D3-T medium at ß2 × 10 5 cells/ml. Shake cells at 220 rpm, 21°C
5. When the cell density reaches ß3 × 10 6 cells/ml, dilute shaking cultures into fresh medium at 2 × 10 5 cells/ml and add to new flasks to expand cell culture if needed.
Preparation of cells for assay 6. At <3 × 10 6 cells/ml, pellet the number of cells needed (1.23 × 10 7 cells/plate) by centrifugation for 5 min at 1000 × g, room temperature. Wash cells twice with DB starvation buffer and pellet cells again at room temperature.
7. Resuspend cells in DB starvation buffer at desirable densities (for aggregation assay, 2.67 × 10 6 cells/ml; for cytotoxicity assay, 2.5 × 10 5 cells/ml).
Preparation of compound plates
8. Dissolve all of the compounds, including those in the test libraries, and the controls (latrunculin A and hygromycin B), in 100% DMSO at 10 mM stock concentration. Store compounds at −20°C in small aliquots, protected from moisture and light.
The compounds will be stable for several years if repeated freeze/thaw cycles are avoided.
9. For the controls, compounds, dilute the stock solution of latrunculin A (for aggregation assay) or hygromycin B (for cytotoxicity assay; see Basic Protocol 2) with DMSO in 384-well plates at a 1:3 titration ratio over 16 serial concentration dilutions, and then format to 1536-well compound plates using an Evolution P3 system (Inglese et al., 2006) . Seal the control compound plate by thermal sealer. Store compound plate at −20°C, protected from moisture and light. The compound plate will be good for several months. 12. Add 23 nl/well of the control compound to the four left-most rows from the control compound plate using the Pintool Station.
The left-most vertical row of cells should have 16 serially diluted concentrations of latrunculin A with duplicates of each dose (Fig. 12.11.2) . Although the top-most wells have no GFP signal, due to the highest concentrations of inhibitor, other wells show varying degrees of brightness, without a precise linear dilution effect (see Fig. 12.11.3 16. Peel off the seal and measure the GFP signals in the 1536-well plate using Acumen e X3 with excitation at 455 to 488 nm and emission at 500 to 530 nm.
The object threshold setting for the Acumen e X3 plate reader is set at >30 μm diameter (>3 cell equivalents) to detect signal from aggregates only.
BASIC PROTOCOL 2 DICTYOSTELIUM CYTOTOXICITY ASSAY FOR ELIMINATING CYTOTOXIC COMPOUNDS
Cytotoxic compounds can also suppress chemotaxis, aggregate formation, and GFP expression, and would, thus, be falsely identified as chemotaxis/migration inhibitors.
To eliminate these false positive compounds, we adapted an ATP content assay for measuring Dictyostelium viability. In this assay, ATP content is proportional to the emitted luminescence produced by the reaction of ATP with added luciferase and D-luciferin. The intensity of the emitted luminescence is measured using the CCD-imager-based ViewLux plate reader. Hygromycin B is used as a cytotoxic control. Since it is difficult to lyse cells in tight aggregates, we use 500 cells/well, which is non-permissive for chemotaxis/aggregation and optimal for the ATP-content assay. Hygromycin B exhibited similar IC 50 values for inhibition of ATP content and chemotaxis (Fig. 12.11.4; Liao et al., 2016) . We use 3 days as an optimal incubation time for measuring compound cytotoxicity. Some compounds might inhibit chemotaxis at lower concentrations than for cytotoxicity. These compounds can be also identified as chemotaxis inhibitors when careful cutoffs are chosen (e.g., at 10-fold differences in IC 50 values).
Materials
Hygromycin B (Sigma-Aldrich) ATPlite assay kit (PerkinElmer, cat. no. 6016731) CCD-imager based ViewLux plate reader (PerkinElmer)
Additional reagents and equipment for Dictyostelium aggregation assay (Basic Protocol 1)
1. Culture and harvest Dictyostelium and prepare cells for assay as described in Basic Protocol 1, steps 1 to 7. At step 7, resuspend cells in DB starvation buffer at 2.5 × 10 5 cells/ml. 
DATA ANALYSIS
The screening data are analyzed by NCATS-developed software, as described in detail in Southall et al. (2009) . IC 50 values are obtained by data fit using a residual error minimization algorithm with automatic outlier determination to a 4-parameter Hill. Concentrationeffect relationships (CERs) were categorized by fit quality (r 2 ), response magnitude, and degree of measured activity (Southall et al., 2009) .
SUPPORT PROTOCOL 2
RE-CONFIRMATION AND VALIDATION OF CHEMOTAXIS INHIBITION
Once non-cytotoxic inhibitors of chemotaxis are identified in a primary screen, they should be re-assayed to confirm the results. Selected compounds are diluted with DMSO in 384-well plates at a 1:3 titration ratio over 12 serial concentration dilutions, and then formatted to 1536-well compound plates (see Basic Protocol 2). Dictyostelium aggregation and cytotoxicity assays are performed as described above. This step will further eliminate both false positives and false negatives, and better define IC 50 values. Inhibitory compounds are then validated for effects on mammalian cells using various direct assays (see below).
REAGENTS AND SOLUTIONS
Use deionized, distilled water in all recipes and protocol steps. For common stock solutions, see APPENDIX 2A.
D3-T medium for Dictyostelium culture
7.15 g of peptone (BD Bioscience, cat. no. 211693) 7.15 g of thiotone (BD Bioscience, cat. no. 211921) 7.15 g of yeast extract (BD Bioscience, cat. no. 212750) 15.4 g of D-glucose 0.48 g of KH 2 PO 4 0.525 g of Na 2 HPO 4 7H 2 O Bring to 1 liter with distilled water and adjust the pH to 6.5 Autoclave for 20 min to sterilize Store in dark up to 6 months at room temperature DB starvation buffer 7.4 mM NaH 2 PO 4 H 2 O 4 mM Na 2 HPO 4 7H 2 O 2 mM MgCl 2 0.2 mM CaCl 2 Bring to 1 liter with distilled water and adjust the pH to 6.5 Store up to 6 months at room temperature HTS assay for cell chemotaxis and migration inhibitors 12.11.8
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Background Information
Discovering chemotaxis inhibitors is important to further understand the molecular mechanisms of chemotaxis and to develop new therapeutics against cancer metastasis, chronic inflammation, etc. (Chan and Mooney, 2008; Jin et al., 2008; Mackay, 2008; Djekic et al., 2009; Su et al., 2009; Wu et al., 2009; Inamdar et al., 2010) . Previous in vitro drug screens for compounds against inflammatory and metastatic processes mainly focused on specific molecules/pathways involved in cell chemotaxis/migration (Mackay, 2008; Djekic et al., 2009; Su et al., 2009; Wu et al., 2009; Inamdar et al., 2010) . Furthermore, compounds identified in these target-based screens have not had high in vivo activity, and few have been applied in clinical trials. Instead, cellbased assays are more favorable to identify compounds that function well in vivo.
The most common chemotaxis assays (e.g., monolayer scratch assay, transwell assay, and EZ-TAXIScan assay) are not easily adaptable for high-throughput screening. 96-well formats can be modified and automated for microfluidic devices (Irimia and Toner, 2009; Berthier et al., 2013; Wu et al., 2013; Guckenberger et al., 2015) , Boyden chambers (Mastyugin et al., 2004; Hulkower and Herber, 2011) , and several image-based assays (Ponath et al., 2000; Mastyugin et al., 2004; Kato et al., 2008; Soltaninassab et al., 2008; Hattori et al., 2010; Hulkower and Herber, 2011; Berthier et al., 2013; Timm et al., 2013; Wu et al., 2013; Guckenberger et al., 2015) , but they are not optimally compatible to screen ß1000 compounds. We are able to screen >10,000 compounds over 5-log concentrations for both chemotaxis and viability.
Critical Parameters and Troubleshooting
We have optimized cell density, incubation time, incubation temperature, mini-well buffer volume, and image-detection parameters for the Acumen e X3, as described above. Accurate temperature control is essential to obtain experimental consistency. The cytotoxicity assay should be performed at non-aggregating cell densities (500 cells/well).
The Acumen e X3 records numbers of aggregates, total fluorescence intensity, and peak fluorescence intensity of aggregates within each well. The GFP peak intensity was the most consistent and was chosen as the primary readout. We have tried to quantify the GFP signal using a CCD-imager-based plate reader (ViewLux from PerkinElmer) and a PMT-based plate reader (EnVision from PerkinElmer), but neither were able to obtain consistent signals.
Since the GFP-expressing multicellular aggregates form randomly, with different sizes and numbers, fluorescence signals can vary enormously [coefficient of variation (CV) = 27%)] from well to well, even without chemical treatment. The Z factor of the aggregation assay is 0.47, which is normally not favorable for a screening assay. However, when the parameters of the laser-scanning plate cytometer are set to quantify only GFP fluorescence presented in multicellular aggregates, the signals from wells with aggregation completely inhibited is "zero." Consequently, the signalto-basal ratio is unique in approaching infinity, emphasizing the extreme robustness and reliability of the assay.
Interestingly, partial inhibition of the GFP signal was rarely observed. Cells either completed aggregation and expressed GFP or remained as individual cells without expressing GFP. These observations can be partly explained by the characteristics of Dictyostelium signal-response. Cells both release and respond to secreted cAMP, in a positive feedback loop (Van Haastert and Veltman, 2007; Jin et al., 2008; McMains et al., 2008; Swaney et al., 2010; Jin, 2013; Artemenko et al., 2014) . In addition, their networks are cross-regulated. Thus, compounds that inhibit chemotaxis often also inhibit cAMP signaling, which would further suppress aggregate formation and GFP expression, amplifying the inhibitory affect. The wells are best classified in a binary fashion, as aggregation/GFP-positive or -negative.
Anticipated Results/Validation
In our pioneer screening from the LOPAC library of 1280 compounds (Liao et al., 2016) , 2 out of 22 primary inhibitory compounds were not also cytotoxic ( Fig. 12.11 .5), using the parallel ATP content assay.
Other false positives for chemotaxis inhibition (e.g., blocking cAMP synthesis, loss of starvation sensing) would not be excluded from the ATP content assay, but they are easily eliminated by the direct chemotaxis assay [e.g., EZ-TAXIScan assay (Fig. 12.11.6 ), transwell assay, and monolayer scratch assay], and none of these were identified in the LOPAC screen. There are at least six intracellular signaling pathway arms that regulate chemotaxis in Dictyostelium (Van Haastert and Veltman, 2007; Jin et al., 2008; McMains et al., 2008; Swaney et al., 2010; Jin, 2013; Artemenko et al., 2014) . Genetically deficient Dictyostelium strains, in which some key components of known chemotaxis pathways have been deleted, might be used to increase the sensitivity of the screen and to screen potent inhibitors for specific chemotaxis pathways. To date, chemotaxis inhibitors have not been identified with nanomolar activities (e.g., Fig. 12.11 .5).
The Dictyostelium aggregation assay that we developed is simple and robust, and was the first cell-based chemotaxis assay compatible with extreme high-throughput screening. Although compounds were identified in a screen that inhibits Dictyostelium chemotaxis, they were similarly able to inhibit chemotaxis of human neutrophils (Fig. 12.11.6 ).
In addition, this assay may also be used to screen for small molecules that regulate the chemotactic response, but not inhibit it. 10 compounds (<10 μM) were identified that increased aggregate numbers/well, thereby reducing aggregate size formation but without blocking GFP expression ( Fig. 12.11 .7) and >10 compounds supported GFP expression under conditions that were normally non-permissive (e.g., <2,000 cells/well) for Dictyostelium chemotaxis and aggregation ( Fig. 12.11.8 ).
Time Considerations
Growth of a Dictyostelium axenic culture in suspension takes ß2 days. Harvesting and resuspension will take ß30 min. It will take ß3 min/plate to dispense cells and compounds to all wells. Incubation of Dictyostelium with compounds for the chemotaxis/aggregation assay takes 2 days. Incubation of Dictyostelium with compounds for the cytotoxicity assay takes 3 days. It takes ß10 min/plate to scan a chemotaxis/aggregation assay for GFP signals. It takes ß2 min/plate to scan a cytotoxicity assay.
